AG 1703
Alternative Names: AG-1703Latest Information Update: 28 Dec 2025
At a glance
- Originator Ahn-Gook Pharmaceutical
- Class Analgesics; Anti-inflammatories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Dec 2025 No recent reports of development identified for research development in Unspecified in South Korea
- 01 Nov 2021 Early research in Unspecified in South Korea (Ahn-Gook Pharmaceutical pipeline, November 2021)